Utah Medical’s 483
This article was originally published in The Gray Sheet
Executive Summary
Response to FDA quality system inspection observations (form FDA-483) addresses an alleged lack of injection molding and extrusion operation validation, the firm says. The Salt Lake City firm, which has pending lawsuits against FDA seeking access to export certificates that have been denied due to alleged QS/GMP non-compliance dating to 2001, asserts it "has been and is in compliance with a reasonable interpretation" of FDA quality system regulations (1"The Gray Sheet" March 1, 2004, p. 14). The Feb. 2 through March 3 inspection report does not cite a lack of sterilization validation or failure to follow MDR report procedures, as was alleged after a 2003 inspection, the firm claims. "There were no current observations to suggest or support concern" about device safety or effectiveness, Utah says...
You may also be interested in...
Utah Medical Sues FDA For Export Certificates Denied Over GMP Findings
Utah Medical cites FDA's refusal to engage in "meaningful" dialogue about alleged good manufacturing practice deficiencies since 2001 as the origin of a dispute that has yielded two lawsuits against the agency
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.